JNE Partners LLP - Q4 2021 holdings

$153 Million is the total value of JNE Partners LLP's 13 reported holdings in Q4 2021. The portfolio turnover from Q3 2021 to Q4 2021 was 0.0% .

 Value Shares↓ Weighting
CMCSA  COMCAST CORP NEWcl a$28,281,000
-10.0%
561,9020.0%18.54%
+4.6%
CP  CANADIAN PAC RY LTD$22,035,000
+10.6%
306,3000.0%14.44%
+28.5%
BABA BuyALIBABA GROUP HLDG LTDsponsored ads$20,539,000
+23.1%
172,900
+53.4%
13.46%
+43.1%
MSDAU  MSD ACQUISITION CORPunit 03/25/2026$15,240,000
+1.5%
1,500,0000.0%9.99%
+18.0%
ORIAU  ORION BIOTECH OPPORTUNTES COunit 04/15/2025$14,790,000
-0.4%
1,500,0000.0%9.69%
+15.8%
NG  NOVAGOLD RES INC$13,412,000
-0.3%
1,955,0470.0%8.79%
+15.9%
EOCWU  ELLIOTT OPPORTUNITY II CORPunit 99/99/9999$11,011,000
-1.1%
1,100,0000.0%7.22%
+15.0%
WALD  WALDENCAST ACQUISITION CORP$9,950,000
+1.5%
1,000,0000.0%6.52%
+18.0%
BATRK  LIBERTY MEDIA CORP DEL$5,676,000
+6.4%
202,0000.0%3.72%
+23.6%
UHAL SellAMERCO$4,648,000
-85.8%
6,400
-87.4%
3.05%
-83.5%
RKTAU  ROCKET INTERNET GRWT OPRT COunit 99/99/9999$4,277,000
-0.4%
430,2340.0%2.80%
+15.8%
KAHCU  KKR ACQUISITION HOLDING I COunit 99/99/9999$2,303,000
+0.4%
229,8660.0%1.51%
+16.7%
WALDW  WALDENCAST ACQUISITION CORP*w exp 03/11/202$403,000
+40.4%
333,3330.0%0.26%
+63.0%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2022-02-15
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
NOVAGOLD RES INC16Q3 202334.9%
AMERCO11Q3 202240.0%
ELLIOTT OPPORTUNITY II CORP9Q2 202319.8%
COMCAST CORP NEW8Q1 202223.5%
ORION BIOTECH OPPORTUNTES CO8Q1 202311.1%
MSD ACQUISITION CORP8Q4 202211.1%
LIBERTY MEDIA CORP DEL8Q2 202313.9%
ROCKET INTERNET GRWT OPRT CO8Q4 20223.2%
KKR ACQUISITION HOLDING I CO7Q3 20221.7%
MICRON TECHNOLOGY INC5Q3 202356.9%

View JNE Partners LLP's complete holdings history.

Latest significant ownerships (13-D/G)
JNE Partners LLP Q4 2021 significant holdings filed using form 13D/G when ownership exceeds 5% of a company's total stock issue.
FiledShares Percentage
Prevail Therapeutics Inc.January 29, 2021? ?

View JNE Partners LLP's complete significant-ownership history.

Latest filings
TypeFiled
13F-HR2024-02-14
13F-HR2023-11-14
13F-HR2023-08-14
13F-HR2023-05-15
13F-HR2023-02-14
13F-HR2022-11-14
13F-HR2022-08-15
13F-HR2022-05-16
13F-HR2022-02-15
13F-HR2021-11-15

View JNE Partners LLP's complete filings history.

Compare quarters

Export JNE Partners LLP's holdings